2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Thymoma: new trials by email Literature Review of Thymoma trials Research Report on Thymoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Folinic Acid for Prevention of Pemetrexed-induced Toxicity Folinic acid - NSCLC, Mesothelioma | Phase 4 | Unknown | Amphia Hospital | 50 | 2023-02-06 | 2023-08-24 |
| Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma Chemotherapy+Pembrolizumab. - Thymoma and Thymic Carcinoma | Phase 4 | Unknown | Tang-Du Hospital | 40 | 2020-08-27 | 2020-10-28 |
Mesothelioma (1)
Hemic and Lymphatic Diseases (2) · Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Complex and Mixed (2) · Thoracic Neoplasms (2) · Thymus Neoplasms (2) · Adenoma (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Mesothelial (1)
130-nm albumin-bound paclitaxel (1) · Leucovorin (1)
Amphia Hospital (1) · Tang-Du Hospital (1)
China (1) · Netherlands (1)
Yongan Zhou (1)